about
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsAlemtuzumab in Multiple Sclerosis: Mechanism of Action and BeyondT-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppressionSecondary autoimmune diseases following alemtuzumab therapy for multiple sclerosisOccurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisA novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanismsAgeing combines CD4 T cell lymphopenia in secondary lymphoid organs and T cell accumulation in gut associated lymphoid tissue.Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitisMislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody productionIRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway.Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotIL-7 in human health and disease.Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunityHaematopoietic stem cell transplantation for autoimmune diseases.IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)Role of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosisProteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseasesImmune dysregulation in myelodysplastic syndrome.Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditionsAltered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndromeLoss of immunological tolerance in Gimap5-deficient mice is associated with loss of Foxo in CD4+ T cells.The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primatesALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.TGF-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferationSelective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease.Homeostasis of lymphocytes and monocytes in frequent blood donors.Toll-like receptors in tumor immunotherapy.Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.Immunosuppression in islet transplantationIdiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells.
P2860
Q26774211-581B897A-66B7-43E5-B263-9B7A322257D7Q26800128-1F2445A7-E438-4C45-82AC-7C48C081562DQ26823892-9235C064-C064-477B-84B6-5517D763F9A6Q28260587-ADF11C77-BE33-4384-9DA3-38D1A9131D3CQ28553133-788AB938-5486-49EA-96D3-DFEC15C1C139Q30379272-55861A0D-3BAE-4EAC-9890-A021D174F3B0Q30428016-C337C5A8-207E-4A7D-8F4C-E3A6F69C820FQ33367125-9A3513B4-A9F4-46D0-ADCF-51318B95A0B4Q33609175-07AAD742-9094-429F-996F-0669B6BAD5A5Q33815631-20FDEE5A-1C79-4A1F-A02E-E6EB330B1282Q33902387-01E1EBFC-D4EF-479E-A824-BB333D018591Q34060500-9404A6D0-AAC9-42EA-A856-88108D3BB260Q34062484-AB79C905-D780-4327-A04F-D23FAACC9EBAQ34079316-BC73D59C-801B-411D-AFD7-E5F9918D220DQ34110205-FAB182AD-1D56-47ED-A470-BDE5FE501CF9Q34180369-D1A8F985-15AC-474B-B5CF-FD0A128CD358Q34260682-0B473C41-076B-40B2-B179-EE91118B5038Q34310523-73922EF5-763D-4104-9EDB-9F97B607E422Q34318285-6408C4EF-1BD7-410E-8D18-9892229A30D9Q34360174-2C9BA3C2-247C-4D70-AA4F-201CE8C0FD8AQ34551863-485014CB-4050-4A72-91BE-685185621CEEQ34988311-C07D5D25-00B2-40A8-B1BF-B11AC341E0B3Q35159893-9F919726-EC7D-4D0D-905A-E95E2E3A15F2Q35175394-765BD148-FEBA-430D-B00D-9C79C85845C1Q35567932-5C3CAE63-8AA8-421D-8165-7761D27D9E83Q35629217-765D3FB9-68D1-445B-838E-0EC699FEFD82Q35657367-79D8E142-277A-4EC5-9002-730CBD5C1125Q35673283-728C84D4-CD1F-4D80-AE4F-D1B6225C54F5Q35946179-5D1E7C2F-A3E4-4992-8211-9B57135BCF9CQ35953466-CFE3C055-DBD6-4760-B59E-7F2C6B8A4774Q35990687-4DAAFCB3-7030-4400-8C62-631025224915Q36049350-865AA6FF-BCE9-4294-A413-46E9460629D4Q36105996-26619B79-D587-4A70-A165-B73FC686EB15Q36180344-F0288B7C-4B63-415C-8360-5323ABADE6AEQ36253608-F01C88F2-DB17-4E5C-9EB1-C01B9208D8C1Q36399264-DA4C773A-BD17-412A-8B3B-5640B16B6C94Q36426562-D0D46CB7-011F-48DB-A394-2DB8F5F9B684Q36498454-F8CE8762-0727-4347-B727-EFD980A3AEE3Q36570514-74E03A4C-4E2E-4E3D-BAC3-0339602B9985Q36633448-7F59602D-DEBB-496C-8040-E05E2A02CE05
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Autoimmunity during lymphopenia: a two-hit model.
@ast
Autoimmunity during lymphopenia: a two-hit model.
@en
type
label
Autoimmunity during lymphopenia: a two-hit model.
@ast
Autoimmunity during lymphopenia: a two-hit model.
@en
prefLabel
Autoimmunity during lymphopenia: a two-hit model.
@ast
Autoimmunity during lymphopenia: a two-hit model.
@en
P2093
P1433
P1476
Autoimmunity during lymphopenia: a two-hit model.
@en
P2093
Crystal L Mackall
Terry J Fry
Tom Krupica
P304
P356
10.1016/J.CLIM.2006.04.569
P577
2006-08-01T00:00:00Z